Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-4305 next-day driving performance multiple-dose study in healthy adults
NL-OMON35772Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of suvorexant in Insomnia (4 arms), sponsored by Merck & Co. Started May 2011; status: active, not recruiting.
02
Drugs
suvorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NL-OMON35772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35772.